Breast cancer is one of the most common malignancies and a leading cause of cancer-related mortality among women worldwide. The elements of group XIV in the periodic table exhibit a wide range of chemical manners. Recently, there have been remarkable developments in the field of nanobiomedical research, especially in the application of engineered nanomaterials in biomedical applications. In this review, we concentrate on the recent investigations on the antiproliferative effects of nanomaterials of the elements of group XIV in the periodic table on breast cancer cells. In this review, the data available on nanomaterials of group XIV for breast cancer treatment has been documented, providing a useful insight into tumor biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.
Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment / Hekmat, Azadeh; Saso, Luciano; Lather, Viney; Pandita, Deepti; Kostova, Irena; Akbar Saboury, Ali. - In: PHARMACEUTICS. - ISSN 1999-4923. - 14:12(2022), p. 2640. [10.3390/pharmaceutics14122640]
Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment
Luciano Saso;
2022
Abstract
Breast cancer is one of the most common malignancies and a leading cause of cancer-related mortality among women worldwide. The elements of group XIV in the periodic table exhibit a wide range of chemical manners. Recently, there have been remarkable developments in the field of nanobiomedical research, especially in the application of engineered nanomaterials in biomedical applications. In this review, we concentrate on the recent investigations on the antiproliferative effects of nanomaterials of the elements of group XIV in the periodic table on breast cancer cells. In this review, the data available on nanomaterials of group XIV for breast cancer treatment has been documented, providing a useful insight into tumor biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.